Ocular Therapeutix, Inc. (OCUL)
10.27
-0.06
(-0.58%)
USD |
NASDAQ |
Mar 06, 16:00
10.27
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix SG&A Expense (TTM) : 118.30M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Abbott Laboratories | 12.33B |
| EyePoint Plc | 40.32M |
| Quince Therapeutics, Inc. | 15.70M |
| Ernexa Therapeutics, Inc. | 5.284M |